Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)

China flag China · Delayed Price · Currency is CNY
22.56
-0.01 (-0.04%)
Apr 29, 2026, 3:00 PM CST
-2.04%
Market Cap 12.71B
Revenue (ttm) 3.96B
Net Income (ttm) 789.02M
Shares Out 563.16M
EPS (ttm) 1.39
PE Ratio 16.24
Forward PE 14.67
Dividend 0.90 (3.99%)
Ex-Dividend Date Jun 20, 2025
Volume 11,941,719
Average Volume 7,902,985
Open 22.43
Previous Close 22.57
Day's Range 22.35 - 22.57
52-Week Range 20.30 - 24.94
Beta 0.13
RSI 62.35
Earnings Date Apr 28, 2026

About SHA:600285

Henan Lingrui Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China. It operates through Pharmaceutical and Healthcare Division; and Others segments. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, and tinctures, etc. for various indications, including orthopedic, cardiovascular, cerebrovascular, dermatology, pediatrics, respiratory, and anesthesiology. Its products include Tongluoqutong plasters, Peiyuan... [Read more]

Sector Healthcare
Founded 1992
Employees 2,435
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600285
Full Company Profile

Financial Performance

In 2025, SHA:600285's revenue was 3.85 billion, an increase of 10.07% compared to the previous year's 3.50 billion. Earnings were 759.50 million, an increase of 5.11%.

Financial Statements

News

There is no news available yet.